Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02986113 · ClinicalTrials.gov registry record · NA
Men and Providers Preventing Suicide (MAPS)
A NA study of Suicidal Ideation and Suicide, Attempted, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
- 2
- Study locations
NCT02986113: Completed NA study of Suicidal Ideation and Suicide, Attempted, sponsored by University of California, Davis.
NCT02986113 is a NA study of Suicidal Ideation and Suicide, Attempted that has completed, run by University of California, Davis. The registered enrollment target is 93 participants, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (65% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02986113, a NA study of Suicidal Ideation and Suicide, Attempted, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will determine if suicidal middle-aged men who use a personalized computer program addressing suicide risk before a primary care visit are more likely to discuss suicide and accept treatment, reducing their suicide preparatory behaviors and thoughts.This is important because half of all men who die by suicide visit primary care within a month of death, yet few broach the topic, missing chances for prevention.
Conditions Studied
Interventions
- BEHAVIORAL MAPS tailored multimedia patient activation program
- BEHAVIORAL Sleep hygiene video
- BEHAVIORAL Telephone evidence-based follow-up care
- BEHAVIORAL Commitment to Living for Primary Care
Study Locations (2)
California
- Palo Alto Medical Foundation Research Institute - Palo Alto
- University of California Davis Health System - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2016-12 |
| Est. Completion | 2019-09 |
| Phase | NA |
What the finished NCT02986113 record still lists
NCT02986113 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 93 participants, a relatively small participant target, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (65% lower).
The record links to 3 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 4 interventions - of which MAPS tailored multimedia patient activation program is the first listed.
NCT02986113 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02986113 about?
NCT02986113 is a clinical study titled "Men and Providers Preventing Suicide (MAPS)". This study will determine if suicidal middle-aged men who use a personalized computer program addressing suicide risk before a primary care visit are more likely to discuss suicide and accept treatment, reducing their suicide preparatory behaviors and thoughts.This is important because half of all m...
What is the current status of trial NCT02986113?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2016-12. Estimated completion is 2019-09.
What conditions does trial NCT02986113 study?
This clinical trial studies the following conditions: Suicidal Ideation, Suicide, Attempted, Suicidal Intention.
What interventions are being tested in trial NCT02986113?
The interventions under investigation include: MAPS tailored multimedia patient activation program (BEHAVIORAL), Sleep hygiene video (BEHAVIORAL), Telephone evidence-based follow-up care (BEHAVIORAL), Commitment to Living for Primary Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT02986113?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02986113 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02986113's enrollment target sits among peer trials
93 44th of 84 higher than 41 of 84 other Suicidal Ideation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
RECRUITING · NA
-
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Crisis Response Planning for Military Personnel
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02203526 · 93 participants · Phase 1
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- NCT03089554 · 93 participants · Phase 2
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- NCT05000021 · 93 participants · NA
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
- NCT05489887 · 93 participants · Phase 2
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia